Johnson & Johnson released numbers today from their phase 3 clinical trials (the last step before applying for emergency use authorization) and it looks like we may soon have a third viable COVID-19 vaccine in the US.
Source: LifeHacker – What’s Different About the Johnson & Johnson Vaccine?